Wellgistics Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $23.3M | $18.1M | — | — |
| Cost of revenue | $29.8M | $16.4M | — | — |
| Gross profit | -$6.4M | $1.8M | — | — |
| Operating expenses | $87.3M | $7.9M | $2.9M | — |
| Operating income | -$93.7M | -$6.1M | -$2.9M | — |
| Interest expense | $4.6M | $831,467 | $15,081 | — |
| Pretax income | -$101.3M | -$6.9M | -$2.9M | — |
| Net income | -$101.3M | -$6.9M | -$2.9M | — |
| Balance Sheet | ||||
| Cash and equivalents | $42,571 | $1.0M | $1,364 | — |
| Current assets | $2.8M | $15.2M | $338,364 | — |
| Total assets | $30.5M | $57.3M | $338,364 | — |
| Current liabilities | $29.8M | $38.0M | $2.9M | — |
| Total liabilities | $42.9M | $50.6M | $3.2M | — |
| Stockholders' equity | -$12.4M | $6.7M | -$2.9M | -$5,250 |
| Cash Flow Statement | ||||
| Cash from operations | -$10.9M | -$1.2M | -$349,136 | — |
| Depreciation and amortization | $158,804 | $67,616 | — | — |
| Stock-based compensation | $54.8M | $1.1M | — | — |
| Impairments | $12.6M | $0 | — | — |
Shares outstanding 125.7M · Free float 72.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.